Details

Autor(en) / Beteiligte

• Uhl, Maria
• Schoeters, Greet
• Govarts, Eva
• Bil, Wieneke
• Fletcher, Tony
• Haug, Line Småstuen
• Hoogenboom, Ron
• Gundacker, Claudia
• Trier, Xenia
• Fernandez, Mariana F.
• Calvo, Argelia Castaño
• López, Marta Esteban
• Coertjens, Dries
• Santonen, Tiina
• Murínová, Ľubica Palkovičová
• Richterová, Denisa
• Brouwere, Katleen De
• Hauzenberger, Ingrid
• Kolossa-Gehring, Marike
• Halldórsson, Þórhallur Ingi

Titel

PFASs: What can we learn from the European Human Biomonitoring Initiative HBM4EU

Ist Teil von

• International journal of hygiene and environmental health, 2023-05, Vol.250, p.114168-114168, Article 114168

Ort / Verlag

Germany: Elsevier GmbH

Erscheinungsjahr

2023

Quelle

MEDLINE

Beschreibungen/Notizen

• Per- and polyfluoroalkyl substances (PFASs) were one of the priority substance groups selected which have been investigated under the ambitious European Joint programme HBM4EU (2017–2022). In order to answer policy relevant questions concerning exposure and health effects of PFASs in Europe several activities were developed under HBM4EU namely i) synthesis of HBM data generated in Europe prior to HBM4EU by developing new platforms, ii) development of a Quality Assurance/Quality Control Program covering 12 biomarkers of PFASs, iii) aligned and harmonized human biomonitoring studies of PFASs. In addition, some cohort studies (on mother-child exposure, occupational exposure to hexavalent chromium) were initiated, and literature researches on risk assessment of mixtures of PFAS, health effects and effect biomarkers were performed. The HBM4EU Aligned Studies have generated internal exposure reference levels for 12 PFASs in 1957 European teenagers aged 12–18 years. The results showed that serum levels of 14.3% of the teenagers exceeded 6.9 μg/L PFASs, which corresponds to the EFSA guideline value for a tolerable weekly intake (TWI) of 4.4 ng/kg for some of the investigated PFASs (PFOA, PFOS, PFNA and PFHxS). In Northern and Western Europe, 24% of teenagers exceeded this level. The most relevant sources of exposure identified were drinking water and some foods (fish, eggs, offal and locally produced foods). HBM4EU occupational studies also revealed very high levels of PFASs exposure in workers (P95: 192 μg/L in chrome plating facilities), highlighting the importance of monitoring PFASs exposure in specific workplaces. In addition, environmental contaminated hotspots causing high exposure to the population were identified. In conclusion, the frequent and high PFASs exposure evidenced by HBM4EU strongly suggests the need to take all possible measures to prevent further contamination of the European population, in addition to adopting remediation measures in hotspot areas, to protect human health and the environment. HBM4EU findings also support the restriction of the whole group of PFASs. Further, research and definition for additional toxicological dose-effect relationship values for more PFASs compounds is needed. [Display omitted] •Serum PFASs levels were measured in 1957 European teenagers.•A quarter of the teenagers had levels above which health effects cannot be excluded.•Some European workers also had very high serum PFASs levels.•The population living in hotspots has a higher exposure and risk of disease.